361 related articles for article (PubMed ID: 11694079)
1. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.
Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K;
Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079
[TBL] [Abstract][Full Text] [Related]
2. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
3. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
4. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
[TBL] [Abstract][Full Text] [Related]
5. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
[TBL] [Abstract][Full Text] [Related]
6. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
Nübling CM; Unkelbach U; Chudy M; Seitz R
Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
[TBL] [Abstract][Full Text] [Related]
7. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
8. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.
Agarwal N; Chatterjee K; Coshic P; Borgohain M
Transfus Apher Sci; 2013 Dec; 49(3):482-4. PubMed ID: 23541414
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
[TBL] [Abstract][Full Text] [Related]
11. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
13. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
[TBL] [Abstract][Full Text] [Related]
14. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
[TBL] [Abstract][Full Text] [Related]
15. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
[TBL] [Abstract][Full Text] [Related]
16. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
18. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
[TBL] [Abstract][Full Text] [Related]
20. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]